Supercritical fluids processing of recombinant human growth hormone

被引:21
|
作者
Velaga, SP [1 ]
Carlfors, J [1 ]
机构
[1] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden
关键词
supercritical fluids; SEDS; human growth hormone; precipitation; powders; protein; stability;
D O I
10.1081/DDC-200047368
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of the study was to investigate the feasibility of precipitating recombinant human growth hormone (hGH) from aqueous solutions using conventional and modified techniques of solution-enhanced dispersion (SEDS) by supercritical fluids. The study investigated the effect on hGH stability of adding isopropanol either as a cosolvent with the original aqueous protein solution (conventional process) or to the supercritical carbon dioxide before mixing with the aqueous protein solution (modified process). The influence of the addition of sucrose (with or without isopropanol) on the precipitation behavior and stability of the protein was also studied. Experiments were performed under various processing conditions (pressure 100-200 bars and temperature 40-50degreesC), and with various flow rates and solution compositions (CO2/isopropanol and protein solution). Bioanalytical characterization of the resulting powders involved spectrophotometry, sodium dodecyl sulfate-polycrylamide gel electrophoresis, reverse-phase high performance liquid chromatography (RP-HPLC), and size exclusion chromatography. Solid-state characterization was performed using differential scanning calorimetry, X-ray powder diffraction, scanning electron microscopy, and Karl Fischer techniques. Results showed that with both conventional and modified methods, under optimum processing conditions, the presence of sucrose in the solution decreased the destabilizing effects of the solvent and/or process on the structure of hGH. More hGH was dissolved from the precipitated powders containing sucrose than from those containing only isopropanol. Reverse-phase HPLC indicated that about 94% of the hGH was recovered in its native form. The proportion of dimers and oligomers was reduced in the presence of sucrose; about 92% of the soluble protein was present in monomer form under optimal conditions. The remaining undissolved protein was in monomeric form. The precipitated powders were amorphous, containing particulate aggregates in the size range 1-6 mum with 5-10% residual moisture content. In conclusion, hGH was successfully precipitated from aqueous solution using SEDS technology. The presence of sucrose in the protein solution promoted the precipitation of hGH and reduced aggregation and improved dissolution.
引用
收藏
页码:135 / 149
页数:15
相关论文
共 50 条
  • [21] Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice
    Dao-Ming Liang
    Jia-Yong Chen
    Yi Zhang
    Ping Gan
    Jie Lin
    An-Bao Chen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (24) : 3810 - 3813
  • [22] Spectroscopic analysis of recombinant human growth hormone in the presence of sucrose and trehalose
    Kamrani, Solmaz
    Yaghmaei, Parichehreh
    Nikkhah, Maryam
    Hosseinkhani, Saman
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2023, 70 (04) : 1543 - 1553
  • [23] Expression of functional recombinant human growth hormone in transgenic soybean seeds
    Cunha, Nicolau B.
    Murad, Andre M.
    Cipriano, Thais M.
    Araujo, Ana Claudia G.
    Aragao, Francisco J. L.
    Leite, Adilson
    Vianna, Giovanni R.
    McPhee, Timothy R.
    Souza, Gustavo H. M. F.
    Waters, Michael J.
    Rech, Elibio L.
    TRANSGENIC RESEARCH, 2011, 20 (04) : 811 - 826
  • [24] Influence of pH on recombinant human growth hormone production by Pichia pastoris
    Calik, Pinar
    Bayraktar, Eda
    Inankur, Bahar
    Soyaslan, Elif S.
    Sahin, Merve
    Taspinar, Hatice
    Acik, Eda
    Yilmaz, Remziye
    Ozdamar, Tuncer H.
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2010, 85 (12) : 1628 - 1635
  • [25] Expression of functional recombinant human growth hormone in transgenic soybean seeds
    Nicolau B. Cunha
    André M. Murad
    Thaís M. Cipriano
    Ana Cláudia G. Araújo
    Francisco J. L. Aragão
    Adilson Leite
    Giovanni R. Vianna
    Timothy R. McPhee
    Gustavo H. M. F. Souza
    Michael J. Waters
    Elíbio L. Rech
    Transgenic Research, 2011, 20 : 811 - 826
  • [26] Thiol-Disulfide Exchange in Human Growth Hormone
    Chandrasekhar, Saradha
    Moorthy, Balakrishnan S.
    Xie, Ruichao
    Topp, Elizabeth M.
    PHARMACEUTICAL RESEARCH, 2016, 33 (06) : 1370 - 1382
  • [27] Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development
    Cleland, JL
    Johnson, OL
    Putney, S
    Jones, AJS
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) : 71 - 84
  • [28] CHO-recombinant human growth hormone as a protease sensitive reporter protein
    Kunert, Renate
    Steinfellner, Willibald
    Altmann, Friedrich
    Wallner, Jakob
    Katinger, Hermann
    Vorauer-Uhl, Karola
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2009, 84 (04) : 693 - 699
  • [29] Feeding strategy design for recombinant human growth hormone production by Bacillus subtilis
    Burcu Şahin
    Sibel Öztürk
    Pınar Çalık
    Tunçer H. Özdamar
    Bioprocess and Biosystems Engineering, 2015, 38 : 1855 - 1865
  • [30] THE USE OF RECOMBINANT HUMAN GROWTH-HORMONE FOR RADIOIODINATION AND STANDARD PREPARATION IN RADIOIMMUNOASSAY
    RIBELA, MTCP
    MURATA, Y
    MORGANTI, L
    TONIOLO, D
    BARTOLINI, P
    JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 159 (1-2) : 269 - 274